The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer

Radiotherapy and Oncology

Volumn 104, Issue 1, 2012, Pages 67-71

  Van Elmpt, Wouter ^a   De Ruysscher, Dirk ^a   Van Der Salm, Anke ^a   Lakeman, Annemarie ^b   Van Der Stoep, Judith ^a   Emans, Daisy ^a   Damen, Eugène ^b   Öllers, Michel ^a   Sonke, Jan Jakob ^b   Belderbos, José ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Dose escalation; Dose painting; NSCLC; PET; PET boost; Treatment planning

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BRACHIAL PLEXUS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE; MALE; MEDIASTINUM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TUMOR BURDEN;

EID: 84863220641     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2012.03.005     Document Type: Article

References (24)

1. P. Goldstraw, J. Crowley, and K. Chansky The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours J Thorac Oncol 2 2007 706 714 (Pubitemid 47357522)
2. A. Auperin, C. Le Pechoux, and E. Rolland Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer J Clin Oncol 28 2010 2181 2190
3. H.J. Aerts, A.A. van Baardwijk, and S.F. Petit Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)fluorodeoxyglucose-PET-CT scan Radiother Oncol 91 2009 386 392
4. A. Abramyuk, S. Tokalov, and K. Zophel Is pre-therapeutical FDG-PET/CT capable to detect high risk tumor subvolumes responsible for local failure in non-small cell lung cancer? Radiother Oncol 91 2009 399 404
5. H.J. Aerts, G. Bosmans, and A.A. van Baardwijk Stability of 18F-deoxyglucose uptake locations within tumor during radiotherapy for NSCLC: a prospective study Int J Radiat Oncol Biol Phys 71 2008 1402 1407
6. J. Belderbos, L. Uitterhoeve, and N. van Zandwijk Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973) Eur J Cancer 43 2007 114 121 (Pubitemid 46054477)
7. A. van Baardwijk, S. Wanders, and L. Boersma Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer J Clin Oncol 28 2010 1380 1386
8. M. Partridge, M. Ramos, A. Sardaro, and M. Brada Dose escalation for non-small cell lung cancer: analysis and modelling of published literature Radiother Oncol 99 2011 6 11
9. R. Boellaard, W.J. Oyen, and C.J. Hoekstra The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials Eur J Nucl Med Mol Imaging 35 2008 2320 2333
10. De Ruysscher D, Belderbos JS, Das M, et al. CT-based definition of organs at risk for radiotherapy for lung cancer: The Amsterdam-Maastricht atlas; 2010. Available from: http://www.maastro.nl/.
11. D. De Ruysscher, and C.M. Kirsch PET scans in radiotherapy planning of lung cancer Radiother Oncol 96 2010 335 338
12. D. De Ruysscher, C. Faivre-Finn, and U. Nestle European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer J Clin Oncol 28 2010 5301 5310
13. G. Bosmans, J. Buijsen, and A. Dekker An "in silico" clinical trial comparing free breathing, slow and respiration correlated computed tomography in lung cancer patients Radiother Oncol 81 2006 73 80 (Pubitemid 44512055)
14. J.W. Wolthaus, J.J. Sonke, and M. van Herk Comparison of different strategies to use four-dimensional computed tomography in treatment planning for lung cancer patients Int J Radiat Oncol Biol Phys 70 2008 1229 1238 (Pubitemid 351296128)
15. T. Knoos, E. Wieslander, and L. Cozzi Comparison of dose calculation algorithms for treatment planning in external photon beam therapy for clinical situations Phys Med Biol 51 2006 5785 5807 (Pubitemid 46217668)
16. F.M. Kong, T. Ritter, and D.J. Quint Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus Int J Radiat Oncol Biol Phys 81 2010 1442 1457
17. L.B. Marks, R.K. Ten Haken, and M.K. Martel Guest editor's introduction to QUANTEC: a users guide Int J Radiat Oncol Biol Phys 76 2010 S1 S2
18. I. Kappers, H.M. Klomp, and M.G. Koolen Concurrent high-dose radiotherapy with low-dose chemotherapy in patients with non-small cell lung cancer of the superior sulcus Radiother Oncol 101 2011 278 283
19. L.B. Marks, S.M. Bentzen, and J.O. Deasy Radiation dose-volume effects in the lung Int J Radiat Oncol Biol Phys 76 2010 S70 S76
20. A. Sovik, E. Malinen, and D.R. Olsen Strategies for biologic image-guided dose escalation: a review Int J Radiat Oncol Biol Phys 73 2009 650 658
21. S.M. Bentzen, and V. Gregoire Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription Semin Radiat Oncol 21 2011 101 110
22. G. Meijer, J. Steenhuijsen, M. Bal, K. De Jaeger, D. Schuring, and J. Theuws Dose painting by contours versus dose painting by numbers for stage II/III lung cancer: practical implications of using a broad or sharp brush Radiother Oncol 100 2011 396 401
23. M. Witte, G. Shakirin, A. Houweling, H. Peulen, and M. van Herk Dealing with geometric uncertainties in dose painting by numbers: introducing the DeltaVH Radiother Oncol 100 2011 402 406
24. D.S. Moller, A.A. Khalil, M.M. Knap, L.P. Muren, and L. Hoffmann A planning study of radiotherapy dose escalation of PET-active tumour volumes in non-small cell lung cancer patients Acta Oncol 50 2011 883 888